23-Galloylarjunolic acid



Compound IDCDAMM02811
Common name23-Galloylarjunolic acid
IUPAC name10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(3,4,5-trihydroxybenzoyl)oxymethyl]-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
Molecular formulaC37H52O9

Experimental data

Retention time18.96
Adduct[M+H]+
Actual mz641.375
Theoretical mz641.368
Error11.26
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5057

Identifiers and class information

Inchi keyLXTNFTYLTNCGNG-PIIMGDHFNA-N
SmilesO=C(OCC1(C)C(O)C(O)CC2(C)C1CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C(=O)O)CCC43C)C6=CC(O)=C(O)C(O)=C6
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)9
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)640.812
Computed dipole moment(dipole)13.934
Total solvent accessible surface area (SASA)842.632
Hydrophobic component of SASA (FOSA)470.542
Hydrophilic component of SASA (FISA)289.365
Pie component of the SASA (PISA)82.725
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1769.37
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)9.65
Free energy of solvation of dipole (dip^2/V)0.109735
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0280521
Globularity descriptor (glob)0.8396
Predicted polarizability in cubic angstroms (QPpolrz)59.667
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.234
Predicted octanol/gas partition coefficient (QPlogPoct)36.22
Predicted water/gas partition coefficient (QPlogPw)20.586
Predicted octanol/water partition coefficient (QPlogPo/w)4.194
Predicted aqueous solubility (QPlogS)-6.062
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.257
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.714
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4.523
Predicted brain/blood partition coefficient (QPlogBB)-2.716
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.839
Predicted skin permeability, log Kp (QPlogKp)-5.697
PM3 calculated ionization potential (IP(ev))9.022
PM3 calculated electron affinity (EA(eV))0.293
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)0.738
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)37.315
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)183.238
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)3

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA
Q9HC98NEK6Serine/threonine-protein kinase NEK6T78992SEA
Q01064PDE1BPhosphodiesterase 1BT77613SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T77613DI0265Mild neurocognitive disorder[ICD-11: 6D71]Q01064PDE1B

Copyright © 2025